IGCNYSEPharmaceutical PreparationsFiscal year ends December 31
IGC Pharma, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.24−0.00 (-1.63%)
Close on Oct 19, 2026
- Market cap
- $24.28M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Oct 16, 2018(first seen in filings) | 1-for-1062 reverse | Earlier per-share figures multiplied by 1062 |
| Jul 16, 2013(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Apr 19, 2013 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |